AI-ECG to Detect Cardiac Amyloidosis: Strengths, Limitations, and Future Directions

By ACA | September 1, 2023

Joining us today to discuss using AI-ECG to detect cardiac amyloidosis is David M. Harmon, Jr. M.D., cardiology fellow at Mayo Clinic Rochester, Minnesota. Dr. Harmon’s research interests include the clinical application of artificial intelligence electrocardiography and assessing the utility of AI algorithms on wearable devices. Tune in to learn about using AI-ECG to detect cardiac amyloidosis.

Specific topics discussed:
• Can you share a little background as to why AI-ECG for cardiac amyloidosis screening?
• What are some of the most surprising results of your validation study? What are the biggest
limitations you found in this work?
• What are some next steps for this algorithm?

From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi

Visit Mayo Clinic: https://mayocl.in/2COVmlm

Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on Twitter: https://twitter.com/MayoClinic

Posted in Uncategorized